|
|
DOPPS Practice Monitor (DPM)
DOPPS created the DOPPS Practice Monitor (DPM) to provide up-to-date trends in clinical care as the new Prospective Payment System (PPS) for renal dialysis services is implemented in January 2011.
The DPM initiative features a publicly available website that provides timely reports aggregating data from over 140 U.S. dialysis facilities and describing trends in many different clinical aspects of hemodialysis practice across the country.
Visit the DPM on DOPPS.org
|
DOPPS Pilot Studies
To more fully understand factors that influence practice patterns in dialysis care, it is vital to expand the study to include countries with greater variation in practice patterns. The primary aim of these pilot studies is to demonstrate the feasibility of applying the DOPPS protocol to other cultures.
- China: Data collection started for this pilot study in late 2010 and has been completed in three cities – Beijing, Guangzhou, and Shanghai. The DOPPS is working closely with key nephrology opinion leaders in each of the three cities to plan for the future of the DOPPS within China. Preliminary data from the study was presented during the Chinese Society of Nephrology Meeting in October 2011 in Nanjing, China including three abstract presentations.
- Saudi Arabia: This pilot study serves as a model for implementation of DOPPS in Saudi Arabia and potentially in other GCC countries (Bahrain, Kuwait, Oman, Qatar, and UAE). The DOPPS is collaborating with key opinion leaders in Saudi Arabia and the other GCC countries to explore feasibility of expanding the study. Data collection started in October 2011 and is ongoing through the end of the year.
|
|
Featured Article: Interpatient Hemoglobin Variability in Hemodialysis Centers
Facility-level hemoglobin variability may reflect within-patient hemoglobin variability and facility-level anemia-control practices. A recent study by Pisoni et al. demonstrates patient mortality rates were higher with greater facility-level hemoglobin variability. Facility-level hemoglobin variability may be modifiable and its optimization may improve hemodialysis patient survival.
View a complete presentation here.
|